Neuroone Medical Technologies is trading 10.38% up at $2.02 after its August 13, 2026 fiscal third-quarter earnings report highlighted record gross margin.
- Product revenue rose 16% to $2.0 million, orders increased 43% to $2.7 million, and gross margin reached a record 59.9%.
- The company lowered recognized-revenue guidance to $9.2 million-$10.5 million because manufacturing constraints delayed shipments.
- Investors appear focused on demand, backlog, and margin expansion.